Vita Life Sciences Ltd Asset Resilience Ratio
Vita Life Sciences Ltd asset resilience ratio. Vita Life Sciences Ltd (VLS) has an Asset Resilience Ratio of 39.38% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VLS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Vita Life Sciences Ltd (2015–2024)
Asset resilience ratio of Vita Life Sciences Ltd from 2015 to 2024. This chart shows how Vita Life Sciences Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Vita Life Sciences Ltd carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Vita Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VLS total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$29.40 Million | 39.38% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$29.40 Million | 39.38% |
Asset Resilience Insights
- Very High Liquidity: Vita Life Sciences Ltd maintains exceptional liquid asset reserves at 39.38% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Vita Life Sciences Ltd Industry Peers by Asset Resilience Ratio
Compare Vita Life Sciences Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Vita Life Sciences Ltd Asset Resilience Ratio by Year (2015–2024)
Vita Life Sciences Ltd asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Vita Life Sciences Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 29.90% | AU$21.50 Million ≈ $15.21 Million |
AU$71.89 Million ≈ $50.87 Million |
-2.21pp |
| 2023-12-31 | 32.11% | AU$19.20 Million ≈ $13.59 Million |
AU$59.81 Million ≈ $42.32 Million |
+24.68pp |
| 2022-12-31 | 7.42% | AU$3.85 Million ≈ $2.72 Million |
AU$51.80 Million ≈ $36.65 Million |
-5.81pp |
| 2021-12-31 | 13.23% | AU$5.99 Million ≈ $4.24 Million |
AU$45.27 Million ≈ $32.03 Million |
+2.03pp |
| 2020-12-31 | 11.21% | AU$4.38 Million ≈ $3.10 Million |
AU$39.10 Million ≈ $27.67 Million |
+5.43pp |
| 2019-12-31 | 5.77% | AU$2.11 Million ≈ $1.49 Million |
AU$36.51 Million ≈ $25.84 Million |
-24.86pp |
| 2018-12-31 | 30.63% | AU$10.94 Million ≈ $7.74 Million |
AU$35.72 Million ≈ $25.27 Million |
+17.52pp |
| 2017-12-31 | 13.11% | AU$4.32 Million ≈ $3.06 Million |
AU$32.95 Million ≈ $23.32 Million |
+7.82pp |
| 2016-12-31 | 5.30% | AU$1.71 Million ≈ $1.21 Million |
AU$32.36 Million ≈ $22.90 Million |
+0.24pp |
| 2015-12-31 | 5.05% | AU$1.64 Million ≈ $1.16 Million |
AU$32.39 Million ≈ $22.92 Million |
-- |
About Vita Life Sciences Ltd
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands… Read more